Top Health Tools
Top Health Tools

Top Reports
Top Reports
 
Top Articles
Top Articles

Top Reviews
Top Reviews
   
New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses


I am thrilled to share with you groundbreaking research demonstrating the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function.

The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant dose-dependent activation of T-cytotoxic cells and Natural Killer (NK) cells. The NK-cell's cancer killing activity was demonstrated against live leukemia cancer cells. The study is published in the journal BMC Complementary and Alternative Medicine. The research focuses on MCP's immune-stimulatory properties in human blood samples, resulting in modulation of different arms of the immune system. Immune researchers at the Dharma Biomedical LLC (Miami, FL) are excited. "The dramatic ability of MCP to activate different components of both the innate (NK-cells) and adaptive (T-cytotoxic) arms of the immune system, demonstrates that MCP can be used in a very strategic manner to support immune function, which may prove useful for a variety of immune compromised health situations," says lead researcher Dr. Steve Melnick. MCP induced an increase in B-cells, T-cytotoxic cells, and NK-cells in a dose dependant manner, meaning the higher the dosage, the greater the effect. Researchers demonstrated that MCP induced a dramatic ten-fold increase in NK-cell activation, and furthermore a significant 53.6% increase in the NK-cells' functional ability to identify and destroy leukemia cancer cells.

Mechanism of Action (How MCP Works)
Melnick further explains, "The Modified Citrus Pectin used in this study consists of various polysaccharides that come in contact with different receptors or proteins on the membranes of immune cells. The immune cells become activated as a consequence of this very specific interaction." Melnick continues, "What I found impressive was the selectivity, and in those cases the magnitude of the effect. For example, polysaccharides derived from mushroom species are known for their immunomodulatory effect. However, in my experience, those effects are considerably lower than observed in the case of T cytotoxic and NK cell activation with this Modified Citrus Pectin." USDA scientists that co-authored the study analyzed the specific structure of this MCP.

Critical Information for Optimal Immune Support
There are two important aspects to the end results of this study when it comes to NK cells. The first one is how many of our NK cells, a specialized subset of T-lymphocytes that destroy infected and cancerous cells are activated by MCP. In other words, how many are awakened from their "sleep" and ready to fight harmful invaders and cancer. MCP exerted a dramatic 10 fold increase in their activation, greater than the positive control Interleukin-2 (IL-2). Additionally, once the NK cells were activated, their actual functional activity level, and specifically against cancer, was demonstrated to be statistically significant.

MCP’s Multiple Cancer-Fighting Properties
This significant increase in T-cytotoxic and NK-cell activation, together with a remarkable increase in NK-cells’ ability to identify and destroy human leukemia cells, proves that the tested MCP is a powerful immune enhancing agent, with the ability to selectively increase cytotoxic immune activity against cancer and infections. With this new data on Modified Citrus Pectin’s powerful immune effects, together with the extensive research on its ability to block cancer-promoting galectin-3 molecules, we now have a much greater understanding of MCP’s significant benefits in fighting and protecting against cancer. Ongoing research continues to demonstrate that MCP possesses numerous anti-cancer mechanisms of action that work to fight cancer from multiple angles.

I have seen first-hand the transformative power of MCP in helping to fight disease and restore health. While I was recommending MCP in my clinical practice for the treatment of cancer and heavy metal toxicity, I had always known that the benefits reached far beyond what had been scientifically proven at the time. After all, many of my patients who came to me for solutions to their chronic diseases became the vibrant examples of how MCP, used as part of an integrative and holistic health program, had not just added years to peoples' lives, but quality as well.  Thanks to this recent landmark immune study, we now know that the powerful immune supporting actions offered by Modified Citrus Pectin represent a significant factor of this vibrant health equation."

Source: Ramachandran, C., Wilk, B.J., Hotchkiss, A.,  Chau, H., Eliaz, I., Melnick, S.J. Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)-Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia Cells with Modified Citrus PectinBMC Complem. Altern. Med.2011, 11:59.

Dr. Isaac Eliaz is a respected author, lecturer, researcher, product formulator, and clinical practitioner. He has been a pioneer in the field of integrative medicine since the early 1980s. Dr. Eliaz is a frequent guest lecturer on integrative medical approaches to health, immune enhancement, and cancer prevention and treatment. For more practical health advice, visit www.dreliaz.org.


Reference Sources
August 17, 2011


Share/Bookmark
...............................................................................................................

This site is owned and operated by PreventDisease.com 1999-2014. All Rights Reserved. All content on this site may be copied, without permission, whether reproduced digitally or in print, provided copyright, reference and source information are intact and use is strictly for not-for-profit purposes. Please review our copyright policy for full details.
aaa
Interact
volunteerDonateWrite For Us
Stay Connected With Our Newsletter